Despite its growing role in tracking MS activity, serum neurofilament light chain lacks diagnostic specificity, experts say.

Researchers still don’t fully understand the cause of multiple sclerosis or why the rate of progression is so difficult to ...

MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...

People with MS who experience chronic lower body pain have altered gait patterns, walking more slowly than those without this ...

CNW/ - EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, is pleased to ...

Multiple sclerosis is an incurable condition that can occur at any point in life However it is most common in young adults – ...

The event is being held to help raise funds and awareness to advance MS research, improve treatments and find a cure for the ...

While MS is still considered rare in India, we’re now seeing a shift toward moderate prevalence,” Dr M V Padma told Business ...

Multiple Sclerosis cases are rising in India, especially among women, with experts stressing early diagnosis, access to ...

Early diagnosis and treatment aim to minimise the impact of multiple sclerosis on their daily lives and extend their ...

Scientists at the University Medical Center Hamburg-Eppendorf (UKE) and Heidelberg University Hospital (UKHD) have ...

Roche shares new data showing its MS drug fenebrutinib maintained low relapse rates and no disability progression in patients ...